EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 180 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 2.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $21,000 | +23.5% | 425 | 0.0% | 0.00% | +100.0% |
| Q4 2018 | $17,000 | -71.2% | 425 | -50.1% | 0.00% | -75.0% |
| Q3 2018 | $59,000 | -15.7% | 852 | -7.9% | 0.00% | -20.0% |
| Q2 2018 | $70,000 | +34.6% | 925 | -7.3% | 0.01% | +66.7% |
| Q1 2018 | $52,000 | -96.8% | 998 | -96.7% | 0.00% | -96.3% |
| Q4 2017 | $1,618,000 | -10.3% | 30,289 | +0.2% | 0.08% | +10.8% |
| Q3 2017 | $1,803,000 | +30.8% | 30,233 | +73.1% | 0.07% | +42.3% |
| Q2 2017 | $1,378,000 | – | 17,465 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |